Stock Market Today: Stocks Start Another Week With a Vaccine Bump
Equities rallied Monday after data showed high efficacy for an AstraZeneca (AZN) vaccine that could be more easily distributed than its peers.


The "rotation" trade returned once more after the market was greeted with COVID vaccine news for a third consecutive Monday.
The heroes today were AstraZeneca (AZN, -1.1%) and the University of Oxford, whose trial vaccine is far easier to store than other vaccines, which could make it easier to distribute across the globe. Trial data revealed an average efficacy of about 70% against COVID – lower than competitors Pfizer (PFE)/BioNTech (BNTX) and Moderna (MRNA), hence AZN's down day – but adjusting dosages could get efficacy up to 90%.
The news prompted a massive spike in cyclical sectors such as financial stocks, up 1.9% as a sector, as well as energy plays such as Exxon Mobil (XOM, +6.6%) and Chevron (CVX, +6.1%) as U.S. crude oil futures climbed 1.5% to $43.06 per barrel. Stocks also enjoyed a bump after learning that President-elect Joe Biden may nominate former Fed chair Janet Yellen as his Treasury Secretary.

Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
The Dow Jones Industrial Average jumped 1.1% to 29,591, while the Nasdaq Composite gained a more subdued 0.2% to 11,880.
Other action in the stock market today:
- The small-cap Russell 2000 closed at another record high, up 1.9% to 1,818.
- The S&P 500 improved by 0.6% to S&P 500.
- Gold futures dropped 1.8% to settle at $1,837 per ounce.
Could 2020 Finish Like It Started?
Wall Street is increasingly warming to the idea that the market could rally into the new year.
"The impending roll-out of multiple highly effective COVID vaccines and the Fed's commitment to backstopping the economy give me confidence that stocks will trade higher into year-end and beyond," says Marc Chaikin, founder of quantitative investment research firm Chaikin Analytics. "I don’t believe that caution is in order and view sideways to downward price action as a buying opportunity.
"The broadening out of the advance to include small cap, value and cyclical stocks, should be accompanied by a robust year-end rally."
If you're looking to leverage value, you can do so either through individual stocks or diversified funds, while these small-cap stocks could make hay as well. The pros also expect further gains for so-called Biden stocks as challenges to his presidential victory thin away.
Another source of gains could come from an unlikely area of the market: consumer staples stocks.
The conventional wisdom goes that staples will be in for a difficult 2021 as vaccines dampen the COVID threat and Americans emerge from their houses. But some staples plays benefit just as much if not more from an outgoing American consumer, and a few others have additional edges on their side as we head into 2021. Read on as we look at some of the best consumer staples stocks for 2021.
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
Kyle Woodley is the Editor-in-Chief of WealthUp, a site dedicated to improving the personal finances and financial literacy of people of all ages. He also writes the weekly The Weekend Tea newsletter, which covers both news and analysis about spending, saving, investing, the economy and more.
Kyle was previously the Senior Investing Editor for Kiplinger.com, and the Managing Editor for InvestorPlace.com before that. His work has appeared in several outlets, including Yahoo! Finance, MSN Money, Barchart, The Globe & Mail and the Nasdaq. He also has appeared as a guest on Fox Business Network and Money Radio, among other shows and podcasts, and he has been quoted in several outlets, including MarketWatch, Vice and Univision. He is a proud graduate of The Ohio State University, where he earned a BA in journalism.
You can check out his thoughts on the markets (and more) at @KyleWoodley.
-
Georgia Could Be Latest State to Eliminate Income Taxes
State Tax Eliminating the Georgia state income tax: Last-minute summer trend or permanent policy?
-
Biggest Winners and Losers in Trump's New Tax Plan
Tax Law Trump’s mega tax overhaul, known as the ‘One Big Beautiful Bill,’ has distinct winners and losers. Which group do you fall into?
-
Wellness Stocks to Invest in Now
Breakthroughs that help us live longer, healthier lives can also create opportunities for investors.
-
If You'd Put $1,000 Into Berkshire Hathaway Stock 20 Years Ago, Here's What You'd Have Today
Berkshire Hathaway is a long-time market beater, but the easy money in BRK.B has already been made.
-
If You'd Put $1,000 Into Procter & Gamble Stock 20 Years Ago, Here's What You'd Have Today
Procter & Gamble stock is a dependable dividend grower, but a disappointing long-term holding.
-
Stock Market Today: Trump Reextends His Tariff Deadline
When it comes to this president, his trade war, the economy, financial markets and uncertainty, "known unknowns" are better than "unknown unknowns."
-
My Three-Day Rule for Investing: And If it Applies Now
Stock Market I've seen a lot in my career. Here's what I see now in the stock market.
-
Is It Time to Invest in Europe?
Stock Market Europe is being shaken out of its lethargy, militarily and otherwise, by Donald Trump's changes in U.S. policy. Should investors start buying?
-
Chevron Stock Declines Despite Another Dividend Hike
Chevron stock is down Friday after the integrated energy company missed fourth-quarter profit expectations. Here's what you need to know.
-
Stock Market Today: Dow Leads as UnitedHealth Stock Pops
UnitedHealth was the best Dow Jones stock Monday on reports that Medicare Advantage payments could rise in 2026.